RxDoctor Payments DataLook up a doctor →

Shivang Joshi, MD

Neurology · Westborough, MANPI 1902034531

Payments from drug & device makers

$1,625,394in general payments, 2019–2025

Across 2,307 payments — averaging $704.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$279K
  • AbbVie$251K
  • Biohaven Pharmaceuticals, Inc.$186K
  • Amgen$186K
  • Ipsen Innovation$157K
  • Eli Lilly$149K
  • plus $419K from 47 others
$31,192in research payments, 2019–2025

Across 12 payments — averaging $2599.36 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$13K
  • Amgen$10K
  • Pfizer$9K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC419$278,794
AbbVie(2 entities)412$250,565
Biohaven Pharmaceuticals, Inc.265$186,096
Amgen179$185,775
Ipsen Innovation86$156,511
Eli Lilly53$148,928
Biohaven Pharmaceutical Holding Company Ltd.106$81,813
Lundbeck LLC89$65,438
Axsome Therapeutics, Inc.38$57,431
Merz Pharmaceuticals, LLC6$43,502
Teva Pharmaceuticals USA, Inc.188$43,391
Impel Pharmaceuticals Inc.40$41,042
Pfizer84$35,992
Currax Pharmaceuticals LLC52$10,852
Scilex Pharmaceuticals Inc.13$7,921
Biodelivery Sciences International, Inc.8$7,254
Impel Pharmaceuticals LLC7$4,792
H. Lundbeck A S7$4,664
Supernus Pharmaceuticals, Inc.34$4,047
Upsher-smith Laboratories LLC35$3,156
Novartis53$2,824
Amneal Pharmaceuticals LLC12$1,893
Tonix Medicines, Inc.6$620
Assertio Therapeutics, Inc.25$335
Eisai Inc.9$201
Otsuka America Pharmaceutical, Inc.13$197
Promius Pharma LLC7$189
Sanofi6$180
Acorda Therapeutics, Inc3$118
Ipsen Biopharmaceuticals, Inc2$79
Arbor Pharmaceuticals, Inc.5$77
UCB, Inc.5$74
Avanir Pharmaceuticals, Inc.4$73
Novocure Inc.5$68
Pernix Therapeutics Holdings, Inc.2$52
AstraZeneca3$51
Livanova USA, Inc.3$49
Harmony Biosciences LLC2$49
Redhill Biopharma Inc.2$48
Acadia Pharmaceuticals Inc2$46
Tersera Therapeutics LLC2$38
Biogen1$28
Zyla Life Sciences, Inc.2$23
Adamas Pharmaceuticals, Inc.1$22
Greenwich Biosciences, Inc.1$16
Shire North American Group Inc1$15
Neurocrine Biosciences, Inc.1$15
Neurelis, Inc.1$13
PTC Therapeutics, Inc.1$12
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$12
Abbott1$12
GE HealthCare1$3
Neurology Practice Consortium GPO, LLC3$0

How this compares

$1,625,394 in reported general payments places this provider in the 95th percentile of 761 neurology providers in Massachusetts.

See all neurology providers in Massachusetts →

Medicare billing

Part B allowed, 2024
$187,814
Medicare patients
127
Services billed
17,354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Westborough

See the full list for Massachusetts →

Where these figures come from

Is this you, or does something look wrong? →